A team led by researchers at the Duke Cancer Institute identified a potential new tactic to disrupt the repair mechanism that cancer cells use after treatment, blunting their ability to regenerate. The approach could present a new treatment strategy.

One of Dr. Kimberly Johnson’s earliest memories of arriving at Duke for her residency in 1997 is the long hallways lined with portraits of white men. Johnson, professor of medicine, has since earned her own place in the hallowed halls of Duke—and beyond.

Duke University School of Medicine ranked No. 6 for research among 124 medical schools nationally in the annual U.S. News & World Report graduate program rankings released today.

School of Medicine faculty and staff were among the recipients of Duke University’s prestigious 2021-22 Duke Presidential Awards, which recognize individuals and teams from the University and Healt

Dr. Ehsan Samei explores new ways to use medical imaging to improve the lives of patients.

Orthopaedic surgery has been labeled “the whitest specialty.” But Erica Taylor, MD, is changing perceptions as Duke’s first Black female orthopaedic surgeon. And in her role as a diversity, equity, and inclusion leader at Duke, she’s working to eliminate inequalities and open doors for future health care leaders.

On Friday, March 18, 2022, fourth-year medical students at Duke opened their envelopes and learned where in the country they will complete residency training. The ceremony took place in person this year at Trent Semans Center for Health Education, after two years of virtual ceremonies. Students are headed to some of the nation’s most prestigious residency programs, with 27 matching at Duke.

SFI St Patrick’s Day Science Medal is awarded annually to U.S.-based scientists, engineers or technology leaders with strong Irish connections, as chosen by an independent selection committee, to recognise their significant contributions to academia and industry and their roles in supporting and engaging with the research ecosystem in Ireland.

In a study that upends current concepts of immunotherapies for breast cancer, researchers at Duke Cancer Institute have described a newly identified process for how the drug pertuzumab works in tandem with trastuzumab.  

Researchers at the Duke Human Vaccine Institute have demonstrated a successful way to deliver a potential HIV vaccine using mRNA technology, like that in the COVID-19 vaccines.